Aberrant human leucocyte antigen‐G expression and its clinical relevance in hepatocellular carcinoma

The clinical relevance of human leucocyte antigen‐G (HLA‐G) has been postulated in malignancies. Hepatocellular carcinoma (HCC) is a major contributor to cancer incidence and mortality worldwide; however, potential roles of HLA‐G in HCC remain unknown. In the current study, HLA‐G expression in 219 p...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of cellular and molecular medicine 2010-08, Vol.14 (8), p.2162-2171
Main Authors:	Lin, A., Chen, H.‐X., Zhu, C.‐C., Zhang, X., Xu, H.‐H., Zhang, J.‐G., Wang, Q., Zhou, W.‐J., Yan, W.‐H.
Format:	Article
Language:	eng
Subjects:	Adult Age Factors Aged Antibodies, Monoclonal - immunology Antibodies, Monoclonal - pharmacology Antigens Binding sites Blotting, Western Carcinoma, Hepatocellular - blood Carcinoma, Hepatocellular - metabolism Carcinoma, Hepatocellular - pathology Cell surface Cells Cytolysis Cytotoxicity Cytotoxicity, Immunologic - drug effects Enzyme-Linked Immunosorbent Assay Female Functional analysis Gene expression Hep G2 Cells Hepatocellular carcinoma Histocompatibility antigen HLA Histocompatibility Antigens Class I - biosynthesis Histocompatibility Antigens Class I - genetics Histocompatibility Antigens Class I - immunology HLA Antigens - biosynthesis HLA Antigens - genetics HLA Antigens - immunology HLA-G Antigens HLA‐G Humans Immunohistochemistry K562 Cells Killer Cells, Natural - cytology Killer Cells, Natural - immunology Lesions Leukocytes Liver Liver cancer Liver Neoplasms - blood Liver Neoplasms - metabolism Liver Neoplasms - pathology Male Middle Aged Natural killer cells Neoplasm Staging NK cell Oncology Patients Tissue Array Analysis Tissues Transfection Tumors
Online Access:	Request full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The clinical relevance of human leucocyte antigen‐G (HLA‐G) has been postulated in malignancies. Hepatocellular carcinoma (HCC) is a major contributor to cancer incidence and mortality worldwide; however, potential roles of HLA‐G in HCC remain unknown. In the current study, HLA‐G expression in 219 primary HCC lesions and their adjacent non‐tumourous samples was analysed with immunohistochemistry. Correlations among HLA‐G expression and various clinical parameters were evaluated. Meanwhile, functional analysis of transfected cell surface HLA‐G expression on NK cell cytolysis was performed in vitro. HLA‐G expression was observed in 50.2% (110/219) of primary HCC lesions, and undetectable in corresponding adjacent normal liver tissues. HLA‐G expression was found in 37.8%, 41.9% and 71.4% of stage I, II and III HCC lesions, respectively. Data revealed that HLA‐G expression in HCC was strongly correlated to advanced disease stage (I versus II, P= 0.882; I versus III, P= 0.020; II versus III, P= 0.037). HLA‐G expression was also more frequently observed in elder patients (≥median 52 years, 57.5%versus 43.4%, P= 0.004). Meanwhile, plasma soluble HLA‐G in HCC patients was significantly higher than that in normal controls (median, 92.49U/ml versus 9.29U/ml, P= 0.000). Functional assay showed that HLA‐G expression in transfected cells could dramatically decrease the NK cell cytolysis (P= 0.036), which could be markedly restored by the blockade of HLA‐G (P= 0.004) and its receptor ILT2 (P= 0.019). Our finding indicated that HLA‐G expression was strongly correlated to advanced disease stage, and more frequently observed in elder patients. Its relevance to HCC progression might be result from the inhibition of NK cell cytolysis.
ISSN:	1582-1838 1582-4934